Lik-Voon Kiew obtained his Ph.D. degree in Biopolymer Technology and Therapeutics from the Universiti Malaya, Malaysia. His research expertise is in the development of nano-sized complexes and particles for (i) anticancer and organ-selective drug delivery and therapy, (ii) antimicrobial/antibiofilm and (iii) bio-sensing / medical diagnosis purposes. He also evaluates synthetic and bioactive compounds/materials for toxicity, physiology impact and disease treatment efficacy. He also assesses the acute and chronic impacts of intravenous administration of nanomaterials to the cardiovascular physiology of rats using radio-telemetry techniques. He has 22 years of research experience in nanomedicine and pharmacology, and has published over 80 research/public articles. He has also been appointed previously as the visiting scientist to the Principe Felipe Research Centre, Valencia, Spain (2014). Kiew is currently a Professor and the Head of the Department of Pharmacology, Faculty of Medicine, Universiti Malaya (UM), Malaysia. He is also a Jointly-appointed Professor of the College of Engineering Bioscience, National Yang Ming Chiao Tung University (NYCU), Taiwan. He has 18 years of experience as a pharmacologist and pharmacology educator, and has been appointed previously as the external examiner (Pharmacology) for the (i)  2025 & 2026 Professional Examination 1 for Year 2 Doctor of Medicine Program, UCSI University, (ii) Second Professional Bachelor of Dental Surgery Examination 2021/2022, International Medical University, Malaysia, (iii) Second Professional Examination 2020/2021, Bachelor of